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Abstract
BACKGROUND Childhood acute lymphoblastic leukemia (ALL) survivors are at risk for
impaired executive function, but it is unclear how to best screen for such impairment. We sought
to determine 1) the reliability of neurocognitive assessment by performance-based testing versus
parent report, and 2) how the measures relate to everyday function.
METHODS 256 survivors of standard risk childhood B-ALL (mean age 13.9 years at
evaluation) were evaluated for executive function with three performance-based measures
(Wechsler Intelligence Scale for Children-IV (WISC-IV), Controlled Oral Word Association
Test, and Conners’ Continuous Performance Test-II) and one parent-report measure (Behavior
Rating Inventory of Executive Function (BRIEF)). The intra-class correlations between measures
were assessed. The relation of the measures to the use of special education services and
stimulants was analyzed with multivariate logistic regression.
RESULTS The reliability between performance-based and parent-reported measures was poor,
with the highest agreement observed between the WISC-IV Working Memory Index and the
BRIEF-Working Memory Scale (kappa=0.143). The use of special education services was
significantly associated with impairment indicated by the BRIEF-WM Scale (odds ratio (OR) =
5.94, 95% confidence interval (CI): 2.97, 12.78) and the WISC-IV WM Index (OR = 3.56, 95%
CI: 1.61, 7.85). Stimulant use was significantly associated with three BRIEF scales (WM,
Inhibit, and Metacognition), but no performance-based measures.
CONCLUSIONS Performance-based and parent-reported measures identified different ALL
survivors with executive function impairment. The association between the parent-reported
BRIEF measures and the use of special education and stimulants suggests that this instrument
has an important value for surveillance.

	
  
Acknowledgements:	
  This	
  research	
  is	
  funded	
  by	
  ACS	
  Grant	
  RSGPB-‐03-‐167-‐01-‐PBP.	
  I	
  would	
  also	
  
like	
  to	
  thank	
  Xiaomei	
  Ma,	
  Ph.D.	
  and	
  Nina	
  Kadan-‐Lottick	
  MD	
  for	
  their	
  continued	
  support	
  in	
  the	
  
preparation	
  of	
  this	
  document.	
  Additionally	
  I	
  would	
  like	
  to	
  thank	
  Lyn	
  Balsamo	
  Ph.D.	
  and	
  Joseph	
  
Neglia,	
  MD	
  	
  for	
  all	
  of	
  their	
  insights.	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  
	
  

3	
  

	
  

4	
  

Table of Contents

List of Tables and Figures

5

Introduction & Literature Review

6-8

Methods

8- 11

Results

11-13

Discussion

14-17

References

18-21

Tables

22-27

Figures

28-29

	
  
	
  
	
  
	
  
	
  
	
  

	
  

5	
  

List of Tables
Table 1: Summary of Standardized Tests Used to Measure Executive Function
Table 2: Demographic Characteristics of Participants	
  
Table 3: Overall Neuropsychological Performance on Performance-Based and Parent-Report
Instruments
Table 4: Kappa Values for Reliability between Parent-Reported and Performance-Based
Measures
Table 5: Relation of Performance-Based and Parent-Reported Measures of Executive Function to
Reported Use of Special Education Services and Stimulants
	
  

List of Figures
Figure 1: Impairment Detected by the BRIEF Working Memory Index and the WISC-IV
Working Memory Index as Compared to Reported use of Special Education Services
Figure 2: Impairment Detected by the BRIEF Working Memory Index and the WISC-IV
Working Memory Index as Compared to Reported Stimulant Use
	
  
	
  
	
  
	
  
	
  
	
  

	
  

6	
  

BACKGROUND
Over 90% of children with acute lymphoblastic leukemia (ALL) will be long-term
survivors, 1 but modern therapy consisting of frequent intrathecal chemotherapy, intensive
systemic chemotherapy, and, occasionally, cranial radiation, can exert neurotoxic effects.2 As a
result, ALL survivors are at an increased risk for neurocognitive impairment as a late
complication of their therapy. Affected cognitive domains include processing speed, attention,
memory, fluency and cognitive organization.3 Each of these specific domains contributes to
overall executive function, “the cognitive abilities necessary for goal-directed behavior and
adaptation to a range of environmental changes and demands”.4 Difficulty with executive
function in childhood cancer survivors has been linked to reduced emotional regulation,5 a
decreased likelihood of living independently as adults, marrying, achieving higher education, and
gaining employment.6-10
Neurocognitive surveillance is recommended by the Children’s Oncology Group LongTerm Follow-Up Guidelines for all childhood ALL survivors because of past neurotoxic
therapy.11 The results of the assessment are used to determine the extent of neurocognitive
evaluation necessary. Ultimately, results are used to determine the need for accommodations in
school (e.g., extra time for work), special education services, and, when appropriate, other
intervention strategies aimed at ameliorating cognitive function such as computer-based
cognitive behavioral rehabilitation 12 or stimulants by prescription.13 Both neuropsychological
testing and patient report (or proxy report) are used to screen for executive function, but it is
unclear which approach is optimal.
Historically, performance-based neuropsychological testing (usually by a psychologist)
has been considered the “gold standard” measurement of executive function. Well-validated and
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standardized measures of executive function are routinely administered to patients to assess
functioning, and identify children with deficits.14-19 However, performance-based testing requires
significant professional resources and can be costly and time consuming. In addition, children
may perform better in these test situations than “real world” settings.20 Therefore,
neuropsychological tests may be limited in the ability to identify children with meaningful
impairment or those at risk for not meeting age- and developmentally appropriate goals.
Executive function assessed by patient/proxy report involves completing surveys
regarding difficulty in real-world situations. The Behavior Rating Inventory of Executive
Function, 21 a standardized parent-report measure, has been used to assess the executive function
of pediatric patients with a variety of conditions.22 Parent-report measures such as the BRIEF
offer several benefits. Scales and questionnaires can be mailed to respondents, require a limited
amount of training to administer and score, and capture the real-world manifestation of functions
such as working memory and task initiation. However, there is concern that anxiety about their
child’s illness may alter parents’ assessment of their child’s executive function, as suggested by
increased levels of reported impairment reported by parents compared with teachers.23 Another
concern regarding parent report is reduced expectations of child’s performance and function,
resulting in deflated reporting of impairment.24
Further research is needed to determine how to best screen for executive function in
survivors of childhood ALL as it relates to meaningful impact on everyday life. We had a unique
opportunity to address this question in a large patient sample from a multi-site long-term followup study of ALL patients treated without cranial radiation. In this study, we determined the
reliability between performance-based and parent-reported measures of executive function, and
evaluated how some dimensions of executive function, specifically working memory, fluency,
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and impulse control measured by the two different approaches, relate to the use of special
education services and stimulants.
METHODS
Study Population
Included in this study are 256 childhood ALL patients who were enrolled in the
Children’s Oncology Group clinical trial protocols 1922 and 1952, which were open March 1993
- August 1995 and May 1996 - February 2000, respectively. Patients were eligible for the current
study if they were diagnosed at one of the 22 designated institutions, were in first remission, and
were 6-16.99 years of age at the time of their executive function evaluation. Other inclusion
criteria included no history of central nervous system leukemia, no history of cranial radiation,
one year or longer since cessation of therapy, no history of pre-existing developmental disorders
(e.g., Down Syndrome, developmental delay), and no history of very low birth weight (<1500
grams). This study methodology has been previously described.25-27 The age restriction
corresponds to the validated age ranges of the standardized neuropsychological instruments used
in the executive functioning evaluation. Informed consent and assent were obtained for all study
participants. The institutional review boards of all participating institutions approved the study
procedures and documents.
Data Collection
Parents of the participating childhood ALL patients completed a questionnaire about the
demographic characteristics and medical history of their children. Parents were asked about their
marital status, education, and income. This questionnaire confirmed that the child was
developing normally before the ALL diagnosis as an additional verification of eligibility for this
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study. In addition, parents provided information on their child’s neurologic events, use of special
education services, and psychotropic drug use during and after ALL therapy.
The patients underwent a comprehensive, half-day, neurocognitive assessment supervised
by a licensed psychologist. This evaluation was conducted at no cost to the patients. The
evaluation included, among others, three performance-based tests: the Wechsler Intelligence
Scale for Children (WISC-IV), the Controlled Oral Word Association Test (COWAT), and the
Conners’ Continuous Performance Test (CPT II). In addition, parents of patients completed the
Behavior Rating Inventory of Executive Function (BRIEF), a standardized parent-report measure
(Table 1).
Table 4 displays impairment categories based on validation studies of these instruments	
  16	
  
21, 28, 29

The WISC-IV: Performance-Based
Patients were asked to perform two tasks from the WISC-IV,	
  28 Digit Span and LetterNumber Sequencing, which comprise the Working Memory Index. Digit span is a measure of
attention and working memory and requires patients to listen to and then repeat series of
numbers of increasing length forwards and then backwards.28 Letter number sequencing
measures attention and working memory. Children listen to a series of letters and numbers and
have to reorganize the numbers in numerical order followed by the letters in alphabetical order.28
The COWAT: Performance-Based
This test is a measure of verbal fluency as measured by an individual’s ability to generate
words beginning with a specific letter. 29 COWAT performance is involves dimensions of
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executive function such as cognitive flexibility, strategy utilization, suppression of interference
and response inhibition, and it has also been proposed to involve the working memory processes
as well. 29 	
  
The CPT-II V.5: Performance-Based
The CPT-II 16 is administered on a computer. Patients are required to press a key as
quickly as possible in response to target letters presented on the computer screen or to refrain
from pressing the key when non-target letters are presented. It measures attention, impulse
control and reaction time. The subscale “Total Commission Errors” measures impulse control,
and “HIT Reaction Time” measures information processing efficiency.	
  16
The BRIEF: Parent-Reported
The BRIEF, 21 contains 86 items comprising eight scales regarding inhibitory control,
ability to shift from one task to another, emotional control, initiation of activity, working
memory, planning/organizing, and work-checking habits.	
  21
Three BRIEF subscales, and one composite scale were used to measure executive
function in this study. These subscales included Working Memory, a 10-item scale; Initiate, an
8-item scale used as a measure of fluency; and Inhibit, a 10-item scale used as a measure of
impulse control. The Metacognition Index reflects an individual’s ability to initiate activity, to
sustain working memory, and to organize one’s materials and environment, among others. 21
Statistical Analyses
Patient characteristics such as age, sex, and history of ALL therapy were summarized as
appropriate.
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Reliability of parent-reported as compared to performance-based measures of impaired
functioning was examined using Cohen’s kappa, a measure of inter-rater agreement.
Multivariate logistic regression models were used to examine the relationship between
performance-based measures of executive function, parent-reported impairment, and patient’s
use of special education services and/or stimulants, adjusting for time since diagnosis, sex and
race. Additionally, a backward stepwise logistic regression model was utilized to identify factors
associated with a single outcome measure termed “everyday impairment,” a combined measure
of a positive history of special education services and/or stimulants.
All analyses were conducted using the software package SAS (version 9.3, Cary, North
Carolina).
Results
Demographic and Clinical Characteristics
The 256 childhood ALL patients included in this study had a mean age of 12.5 years (SD
= 2.4, median = 13) at the time of evaluation, and were on average about 9.19 years post
diagnosis. There were slightly more females (53.0%, n = 136) than males (47.0%, n = 120). Of
note, only one percent of the patients reported receiving special education services before
treatment, as compared to 6.8% during treatment and 20.7% after treatment (p <0.001) (Table 2).
Normative data from the general population for the WISC-IV, the COWAT, the CPT-II
and the BRIEF were used to categorize impaired scores for each test or subscale. Statistically
significant frequencies of impairment greater than the standard population were observed for the
COWAT (p = 0.001), the BRIEF Working Memory subscale (p = 0.005), the BRIEF Initiate
subscale (p = 0.01), and the BRIEF Metacognition Index (p = 0.04). Conversely, statistically

	
  

12	
  

significantly lower frequencies of impairment were observed for the CPT-II Commissions and
Omissions subscales (p < 0.001) (Table 3).	
  	
  
Impairment Classification According to Performance-Based Testing vs. Parent-Reported
Measures
Reliability between impairment classified by performance-based testing versus parentreported measures was assessed using Cohen’s Kappa (Table 4). Of all the performance-based
and the corresponding parent-reported pairs of executive function measures tested (n=7) only
three pairs showed statistically significant agreement: the WISC-IV Working Memory Index and
the BRIEF-Working Memory (kappa = 0.14), the WISC-IV Letter-Number Sequencing and the
BRIEF-Working Memory (kappa = 0.12), and the Controlled Oral Word Association Test and
the BRIEF Initiate (kappa=0.16). Even for these three pairs, the kappa values were close to 0,
indicating poor reliability between the two different approaches.
Association between Impaired Cognition and Reported Use of Special Education Services
The relation between impaired cognition and reported use of special education services
was assessed using multivariate logistic regression models, adjusting for age at evaluation (in
years), gender, and race (white vs. non-white). Of the performance-based measures, impairment
indicated by the WISC-IV Working Memory Index (odds ratio (OR) = 3.56; 95% confidence
interval (CI): 1.61, 7.85; p=0.002) and Digit Span (OR = 3.99; 95%CI: 2.08, 7.65; p < 0.001)
scales as well as the COWAT (OR = 3.70; 95%CI: 1.89, 7.26; p < 0.001) were found to be
significantly associated with an increased likelihood of using special education services (Table
5). Impairment on three of the four BRIEF subscales was also significantly associated with the
same outcome: Working Memory (OR = 5.94; 95%CI: 2.76, 12.78; p < 0.001), Inhibit (OR =
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3.89; 95%CI: 1.59, 9.50; p = 0.003), and the Metacognition Index (OR = 3.80; 95%CI: 1.20,
8.57; p = 0.001).
Of the 60 patients receiving special education services after treatment, 21 (35.0%) were
found to be clinically impaired based on the parent-report BRIEF, while only 15 (25.0%) were
considered clinically impaired based on the performance-based WISC-IV Working Memory
Index. Forty percent of these individuals (n = 24) were not identified as having impairment by
either approach (i.e., performance-based or parent-reported measures) (Figure 1).
Association between Impaired Cognition and Reported Use of Stimulants
Impairment identified through performance-based measures was not associated with
reported use of stimulants in this study population. In contrast, patients who were considered
impaired based on one of the following three parent-reported scales from the BRIEF were
significantly more likely to use stimulants: Working Memory (OR = 7.16; 95% CI 2.97, 20.28; p
< 0.001), Inhibit (OR = 5.21; 95% CI 1.81, 14.98; p= 0.002), and the Metacognition Index (OR =
4.88; 95% CI 1.77, 13.40; p= 0.002) (Table 5).
Of the 23 patients who reported using stimulants, 12 (52.2%) were considered clinically
impaired based on parent-reported BRIEF, and only 2 (8.7%) were identified as having clinically
significant impairment based on the performance-based WISC-IV Working Memory Index
(Figure 2).
Discussion
In this large cross-sectional study of childhood ALL survivors, we examined the utility of
the BRIEF, a standardized parent-report instrument, as compared to performance-based measures
to screen for executive function. Our analysis revealed that there is little concordance between
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these two testing approaches as indicated by low kappa values. Both the performance-based and
parent-reported measures were significantly associated with the use of special education services
after adjusting for years since diagnosis, sex and race. However, the magnitude of association
was larger for the parent-reported BRIEF Working Memory, Inhibit and Metacognition scales.
For stimulant use, only parent-reported scales showed significant association. Our results suggest
that parent report and performance based testing are complementary in identifying at risk
patients. Parent-reported BRIEF scales identified more patients with executive function
impairment who manifested as needing special education services and/or stimulants. If resources
or psychological expertise is limited, the BRIEF is a useful and valuable instrument for
surveillance in this population.
The current study not only examines concordance and discordance between two testing
methodologies, but also considers the application of these tests in terms of ecological validity.
Additionally, the study included a relatively large number of childhood ALL patients who were
treated with contemporary regimens, and had availability of high quality data on both
performance-based and parent-reported measures. Due to the size of the study population, there
was also the ability to examine and control for multiple potential confounders in the analyses.
Consistent with studies in other populations,20 scores on the parent-reported measures in
this ALL population were significantly different from the standard normative population,
reflecting more impairment in this group. Our results also indicate that parents rated their
children as displaying more impairment than suggested by results of performance-based
measures. Parents may be reporting higher levels of impairment, as their responses are based on
continual observations of their child’s behavior in a real life setting, as compared to
performance-based measures, which occur in a structured environment, or “ideal” conditions.
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Others have hypothesized that parental expectations of “normal behavior” may be altered as a
result of their child’s disease and the trauma associated with it; however, our study indicates that
they may be even more sensitive to deficits in their children.
Current findings indicate that performance-based measures were only significantly
associated with reported use of special education services only, while the parent-reported BRIEF
was associated with the use of both special education services and stimulants. Our findings
differed from previous reports. Krull et al. compared the parent-reported Childhood Symptom
Inventory to a range of performance-based neuropsychological tests in 240 survivors of
childhood cancer.	
  30 This report concluded that the parent-report assessment was inferior, but this
instrument was primarily designed to measure emotion and behavior. Furthermore, the two
assessment approaches were compared to achievement scores from the clinical testing
environment, instead of everyday function. Howarth et al. studied the utility of the BRIEF in
detecting working memory problems among 50 childhood brain tumor survivors.	
  20 The results
of this study similarly showed only modest correlations between parent-reported impairment and
performance-based impairment, but in this population, the BRIEF under-classified the number of
patients with working memory impairment. This study was limited in that it only examined one
aspect of executive function, working memory, which may be disproportionately affected in
children who are treated with conformal radiation therapy, as compared to our study sample.
In a study of 199 children with NF1, functional impairment as defined by parent report on
the BRIEF, detected different children than were detected as impaired by cognitive testing31. As
in the current study, there is support that extrapolating real life impairment from performancebased tests may has its limitations.
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Our results do not support a gold standard strategy for the measurement of executive
function in childhood ALL survivors. The performance-based and parent-reported measures
identified different patients as impaired, with minimal overlap. The value of the parent-reported
BRIEF was confirmed, as it was significantly associated with the use of special education
services and stimulants in survivors. Given the considerable cost (often not reimbursed by
insurance), time, and professional expertise needed for traditional neuropsychological testing,
one strategy could be to use the BRIEF for routine surveillance in patients with a history of
neurotoxic treatment exposures who do not complain of acute difficulties. Children with
evidence of impairment on the BRIEF could then undergo follow-up performance-based
neuropsychological testing for a more complete evaluation. Conversely, in settings where
performance-based measures are readily available, there is independent added benefit to
additionally requesting completion of the BRIEF as it has been indicated as an important
surveillance tool that may indicate the need for more comprehensive neuropsychological testing.
We acknowledge several limitations. First, this study employed a cross-sectional design,
which made it infeasible to examine any changes in parent-reported executive function
impairment over time. However, our primary focus was to compare two approaches for
evaluation at a singular point in time, so for the purposes of this analysis, a measurement of
change was not required. Additionally we recognize that stimulant use may alter the results of
performance-based testing, as children who are impaired may fall into normal ranges due to the
effects of the medications. However, the literature has suggested that stimulants are not as
effective in cancer survivors, and thus performance-based testing should still indicate impairment
for many of those taking stimulants.32 Finally, the use of special education services and
stimulants are only two measures of everyday function. Some have argued that factors such as
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socioeconomic status or parental education may effect who gets referred for these specialized
services, with children of parents with higher education or higher SES having a higher rate of
referral. Our data did not show any significant associations between SES nor parental education
with the reported use of special education services or use of stimulants. Other important ones that
were not available in our study include attainment of goal target scores on state administered
tests of achievement, eventual highest level of educational achievement, future income, and later
ability to live independently. Finally, we acknowledge that special education and stimulant
history are meant as proxies for clinically important impairment. However, though parental
education and advocacy can also affect referral for these services/therapies, there was not a
significant relationship between income or parental education level and the use of special
education services or stimulants.
In a population at high risk for cognitive impairment, such as childhood ALL survivors,
there is a strong need for a feasible and ecologically valid form of surveillance. The lack of
concordance between the parent-reported and performance-based measures highlights the
complexity of evaluating domains of executive function, and illustrates the value of
comprehensive testing. When resources are more limited, our results suggest that the parentreported BRIEF, could detect real life impairment, and should be used to supplement
performance-based measures.
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Table 1: Summary of Standardized Tests Used to Measure Executive Function

Measure (with subscales as applicable)

Method of Assessment

Construct Measured

Working Memory Index

Performance

Working Memory

Letter Number Sequencing

Performance

Working Memory

Digit Span

Performance

Working Memory

Performance

Initiation/Fluency

Omissions

Performance

Inattention

Commissions

Performance

Inhibition/Impulsivity

HIT Reaction Time

Performance

Inattention/Impulsivity

Parent Report

Working Memory

Parent Report

Initiation

Parent Report

Inhibition

Parent Report

Working Memory/
Initiation

Wechsler Intelligence Scale for Children-IV

Controlled Oral Word Association Test
Conners’ Continuous Performance Test-II

Behavior Rating Inventory of Executive
Function
Working Memory
Initiate
Inhibit
Metacognition Index
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Table 2: Demographic Characteristics of Participants (n=256)
Column1

Mean (SD) or N (%)

Age at Diagnosis (years)

3.90 (1.65)

Elapsed time between diagnosis and
evaluation (years)

9.19 (1.37)

Age at Evaluation (years)

12.5 (2.44)

Sex (n, %)
Female

136 (53%)

Male

120 (47%)

Race/ethnicity
White, non-Hispanic

207 (82%)

Non-white

44 (18%)

Stimulant Use After Treatment

23 (9.0%)

Special Education Services
Before Treatment

3 (1.2%)

During Treatment

17 (6.8%)

After Treatment

52 (20.7%)
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Table 3: Overall Neuropsychological Performance on Performance-Based and Parent-Report
Instruments
Study Sample

Normative Standardized
Population
Definition of
Impaired
Scores

Expected
Frequency
Clinically
Impaired

T-score

Clinically Impaired

Mean (SD)

N (%)

P-value

Wechsler Intelligence Scale
for Children-IV
Working Memory
Index
Letter Number
Sequencing

< 85 (1SD
below mean)

98.2 (14.4)

16%

38 (14.8)

0.707

< 7 (1SD
below mean)

10.1 (2.8)

16%

32 (12.5)

0.26

9.5 (2.8)

16%

58 (22.6)

0.06

9.3 (2.7)

16%

72 (28.0)

0.001

46.4 (8.2)

15%

10 (3.9)

<0.001

Digit Span

< 7 (1SD
below mean)

Controlled Oral Word
Association Test

< 7 (1SD
below mean)

Conners’ Continuous
Performance Test-II
Omissions

>60 (1SD
below mean)

Commissions

>60 (1SD
below mean)

42.4 (15.3)

15%

10 (3.9)

<0.001

HIT Reaction Time

>60 or <40
(1SD above/
below mean)

42.9 (17.0)

15%

25 (9.8)

<0.001

52.5(12.9)

8.8%

44 (17.2)

0.005

Behavior Rating Inventory of
Executive Function
Working Memory

>65 (1.5SD
above mean)

Initiate

>65 (1.5SD
above mean)

51.7 (11.4)

8.9%

42 (16.4)

0.01

Inhibit

>65 (1.5SD
above mean)

49.5 (12.2)

8.8%

26 (10.1)

0.65

	
  

Metacognition Index

25	
  
>65 (1.5SD
above mean)

50.8 (13.5)

9.5%

40 (15.6)

0.03
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Table 4: Kappa Values for Reliability between Parent-Reported and Performance-Based
Measures

Performance Based Tests

Behavior Rating Inventory of Executive Function
Subscales (Parent-Reported)

Column
5

Working Memory

P-value

Initiate

Inhibit

Metacognition
Index

WISC-IVa Working Memory
Index

0.15

nab

na

na

0.02

WISC-IV Letter-Number
Sequencing

0.11

na

na

na

0.05

WISC-IV Digit Span

0.12

na

na

na

0.08

Controlled Oral Word
Association

na

0.16

na

na

0.007

CPT-IIc Commission

na

na

-0.005

na

0.47

CPT-II Hit Reaction Time

na

na

na

0.02

0.36

CPT-II Omission

na

na

na

0.002

0.49

a

WISC-IV: Wechsler Intelligence Scale for Children IV
na: not applicable
c
CPT-II: Conners’ Continuous Performance Test II
b
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Table 5: Relation of Performance-Based and Parent-Reported Measures of Executive Function to
Reported Use of Special Education Services and Stimulants*
History of Special Education
Services
Measure

*

Method of
Assessment

OR

95% CI

P-value

History of Stimulant Use

OR

95% CI

WISC-IVa Working
Memory Index

Performance

3.56

(1.61,7.85)

0.002

1.74

(0.38, 9.68)

0.47

WISC-IVa Digit Span

Performance

3.99

(2.08, 7.65)

<0.001

1.51

(0.59,3.96)

0.38

Controlled Oral Word
Association Test

Performance

3.70

(1.89, 7.26)

<0.001

1.39

(0.55,3.48)

0.49

BRIEFc Working Memory

Parent

5.94

(2.76,
12.78)

<0.001

7.16

(2.97, 20.28)

<0.001

BRIEFc Inhibit

Parent

3.89

(1.59, 9.50)

0.003

5.21

(1.81, 14.98)

0.002

BRIEFc Metacognition
Index

Parent

3.80

(1.20, 8.57)

0.0012

4.88

(1.77, 13.40)

0.002

Results based on multiple logistic regressions adjusted for time since diagnosis, gender and race
WISC-IV: Wechsler Intelligence Scale for Children IV
b
ns: not significant
c
BRIEF: Behavior Rating Inventory of Executive Function
a

P-value
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Figure 1: Impairment Detected by the BRIEF Working Memory Index and the WISC-IV Working
Memory Index as Compared to Reported use of Special Education Services

Receives	
  Special	
  Education	
  
Services	
  [n=60]	
  
	
  
28*	
  

17	
  
Impairment	
  Based	
  on	
  
BRIEFa	
  Working	
  
Memory	
  [n=44]	
  
	
  
16	
  

11
4
7	
  

*

Impairment	
  Based	
  on	
  
WISC-‐IVb	
  Working	
  
Memory	
  Index	
  [n=35]	
  
	
  
13	
  

Numbers indicated the number of children in each category (eg: “28” in the Receives Special Education
Services indicates that 28 children receive special education services, but did not have impairment
indicated on either instrument; “17” indicates that 17 children receive special education services, and also
were considered impaired on the BRIEF working memory index)
a

Behavior Rating Inventory of Executive Function (Parent-Report)

b

Wechsler Intelligence Scale for Children
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Figure 2: Impairment Detected by the BRIEF Working Memory Index and the WISC-IV Working
Memory Index as Compared to Reported Stimulant Use
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Numbers indicated the number of children in each category (eg: “20” in Reported Stimulant Use
indicates that 20 children use stimulants, but did not have impairment indicated on either instrument; “12”
indicates that 12 children receive special education services, and also were considered impaired on the
BRIEF working memory index)
a

Behavior Rating Inventory of Executive Function (Parent-Report)

b

	
  
	
  
	
  
	
  
	
  
	
  
	
  

Wechsler Intelligence Scale for Children

